Inventor · disambiguated record
Jiaqiang Cai
Also filed as: CAI JIAQIANG
28 granted patents·23 pending applications·32 citations·filing 2005–2024
93Inventor score
Files withSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD17MERCK SHARP & DOHME12ORGANON NV5MEDILINK THERAPEUTICS SUZHOU CO LTD4CAI JIAQIANG3
Top patents by PatentIndex Score
51 records- 0187US10899786B2Nucleoside phosphate compound and preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 26, 2021·5 cites·28 claims
- 0283US10246457B2Indazole and azaindazole Btk inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 0383US7326715B24-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivativesORGANON NV·Filed 2006·Granted Feb 5, 2008·7 cites·12 claims
- 0481US7687515B26-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivativesORGANON NV·Filed 2007·Granted Mar 30, 2010·5 cites·21 claims
- 0580US11667629B2Isoxazole derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 6, 2023·2 cites·16 claims
- 0680US9382226B2Aldosterone synthase inhibitorsHOYT SCOTT B·Filed 2011·Granted Jul 5, 2016·4 cites·16 claims
- 0777US2024382612A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0875US8026236B26-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivativesORGANON NV·Filed 2010·Granted Sep 27, 2011·2 cites·8 claims
- 0974US7932251B26-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivativesORGANON NV·Filed 2008·Granted Apr 26, 2011·2 cites·14 claims
- 1073US2023357259A1Bioactive conjugate, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1171US9725445B2Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 8, 2017·2 cites·17 claims
- 1269US2021040096A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 1366US11970506B2Bioactive molecule conjugate, preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Apr 30, 2024·0 cites·22 claims
- 1466US10087188B2Benzamide imidazopyrazine Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·1 cites·2 claims
- 1562US2019322666A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 1661US2025332272A1Preparation method for drug linker conjugate and intermediate thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1759US2025325688A1Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1859US2025177542A1Preparation method for drug linker conjugateMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1958US2018099967A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 2058US2024108745A1Bioactive substance conjugate, preparation method therefor and use thereofMEDILINK THERAPEUTICS SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 2156US2025144229A1Conjugate of antibody-eribulin or derivative thereof, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and use thereofMEDLINK THERAPEUTICS SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2254US2017190701A1Fused tricyclic heterocyclic compounds as hiv integrase inhibitorsYU TAO·Filed 2016·Application pending·0 cites
- 2353US11186599B2Phosphonamide ester compound, salt thereof, related crystal form thereof, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Nov 30, 2021·0 cites·25 claims
- 2450US2023118497A1Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 2548US11434235B2Solid form of dihydropyrimidine compound and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 6, 2022·0 cites·9 claims
- 2647US11207420B2Cytotoxin and conjugate, uses of same and preparation method thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Dec 28, 2021·0 cites·36 claims
- 2747US11166954B2Dihydropyrimidine compound and preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 9, 2021·0 cites·9 claims
- 2846US2023043863A1Heteroaromatic derivatives for use as regulator, preparation method therefor and use thereofJIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD·Filed 2019·Application pending·0 cites
- 2946US2022017483A1Aminopyridine compound, preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3046US2022340547A1Indole derivative-containing inhibitor, preparation method therefor and application thereofSHANGHI HANSOH BIOSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3145US11541049B2Tetrahydroisoquinoline derivatives, preparation process and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Jan 3, 2023·0 cites·21 claims
- 3245US11266674B2Pharmaceutical composition for tumor treatment or prevention, method, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Granted Mar 8, 2022·0 cites·12 claims
- 3345US2021395226A1Substituted aryl compound and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3443US11292785B2Nitrogen-containing benzoheterocycle compound comprising carboxylic acid group, preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2019·Granted Apr 5, 2022·0 cites·13 claims
- 3543US10233193B2Fused tricyclic heterocyclic compounds useful for treating HIV infectionMERCK SHARP & DOHME·Filed 2016·Granted Mar 19, 2019·0 cites·19 claims
- 3642US2023076435A1Modifier of four-membered ring derivative, preparation method and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2020·Application pending·0 cites
- 3741US10000501B2Inhibitors of HIF prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Granted Jun 19, 2018·0 cites·5 claims
- 3840US11084847B2Polyamide compound and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 10, 2021·0 cites·42 claims
- 3940US10696669B2Dihydropyrimidine compound and preparation method and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 30, 2020·0 cites·9 claims
- 4037US10208047B2Tertiary alcohol imidazopyrazine BTK inhibitorsLIU JIAN·Filed 2015·Granted Feb 19, 2019·0 cites·8 claims
- 4137US2019315771A1Novel 2-acylaminothiazole derivative and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4236US10214546B2Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 26, 2019·0 cites·7 claims
- 4336US10208060B2Inhibitors of HIF prolyl hydroxylaseCAI JIAQIANG·Filed 2015·Granted Feb 19, 2019·0 cites·3 claims
- 4435US7589095B24-phenyl-pyrimidine-2-carbonitrile derivativesORGANON NV·Filed 2005·Granted Sep 15, 2009·0 cites·23 claims
- 4535US2017349593A1Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 4634US9115126B21H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivativesCAI JIAQIANG·Filed 2011·Granted Aug 25, 2015·0 cites·7 claims
- 4733US9969752B2Inhibitors of HIF prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Granted May 15, 2018·0 cites·6 claims
- 4833US2017247336A1Substituted pyrimidines as inhibitors of hif prolyl hydroxylaseMERCK SHARP & DOHME·Filed 2015·Application pending·0 cites
- 4932US2017240513A1Substituted pyrimidines as inhibitors of hif prolyl hydroxylaseUJJAINWALLA FEZ·Filed 2015·Application pending·0 cites
- 5031US2017240511A1Substituted pyridine inhibitors of hif prolyl hydroxylaseUJJAINWALLA FEZ·Filed 2015·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →